Recombinant Antibodies as Therapeutic Agents: Pathways for Modeling New Biodrugs

By Frederico Aires da Silva   Corte-Real Sofia   Goncalves Joao  

BioDrugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 301-314

Adis International

Access to resources Recommend Favorite

Practical Considerations in Converting from Plasma-Derived to Recombinant Hepatitis B Vaccines

By Lee I.   Lee C-Y.  

BioDrugs, Vol. 10, Iss. 1, 1998-07 ,pp. : 11-25

Adis International

Access to resources Recommend Favorite

A comparison of VDRL and immunoassays developed with a recombinant TmpA antigen in the screening of antibodies to Treponema pallidum

By Miranda A.   Benitez J.   Acevedo B.   Dominguez M.d.C.   Villareal A.   Palenzuela D.   Rodriguez L.   Rodriguez J.L.   Nunez Z.   Gavilondo J.V.  

Serodiagnosis and Immunotherapy in Infectious Disease, Vol. 8, Iss. 3, 1997-01 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Efficacy of different second- and third-generation assays for detection of hepatitis C virus antibodies in plasma and sera also tested by polymerase chain reaction

By Pujol F.H.   Blitz-Dorfman L.   Leon G.   Monsalve F.   Echevarria J.M.   Liprandi F.  

Serodiagnosis and Immunotherapy in Infectious Disease, Vol. 7, Iss. 2, 1995-06 ,pp. : 51-54

Elsevier

Access to resources Recommend Favorite

Comparative Immunogenicity of a Genetically Derived and a Plasma Pooled Hepatitis B Vaccine in Normal Adult Volunteers: Immunogénicité du vaccin hépatite B obtenu soit par la technique d’ADN recombinant soit par un pool de plasma : étude chez des volontaires sains adultes

By Nadeem Irfan Bukhari  

Therapie, Vol. 60, Iss. 3, 2005-01 ,pp. : 311-316

Adis International

Access to resources Recommend Favorite